Related Experiment Video

Updated: Jul 20, 2026

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents
07:26

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents

Published on: July 14, 2021

Surgery Insight: surgical methods to reverse left ventricular remodeling

Michele De Bonis1, Ottavio Alfieri

  • 1Department of Cardiac Surgery at San Raffaele University Hospital, Milan, Italy. debonis.michele@hsr.it

Nature Clinical Practice. Cardiovascular Medicine
|August 26, 2006
PubMed

Insights

Surgical interventions can help manage congestive heart failure (CHF) by reversing left ventricular remodeling, a key predictor of mortality. Advanced therapies like gene and cell therapy show promise for future heart failure treatment.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Heart Failure Management

Background:

  • Congestive heart failure (CHF) presents significant management challenges with high mortality rates.
  • Left ventricular dilatation is a primary predictor of mortality in CHF patients.
  • Medical therapy alone often yields suboptimal outcomes for advanced heart failure.

Purpose of the Study:

  • To review common surgical techniques aimed at reversing left ventricular remodeling in CHF.
  • To discuss the role of surgical interventions in improving outcomes for heart failure patients.
  • To explore emerging innovative therapies for heart failure treatment.

Main Methods:

  • Review of current surgical procedures for CHF, including myocardial revascularization, ventricular restoration, and mitral valve repair.
  • Discussion of ventricular assist devices and diastolic support systems.
  • Exploration of novel approaches such as gene therapy, cell therapy, and engineered tissues.

Main Results:

  • Surgical interventions address multiple pathophysiologic components of CHF, often requiring combined approaches.
  • Refined surgical techniques and accumulating data are expected to improve treatment outcomes.
  • Emerging therapies hold potential for significant future advancements in heart failure management.

Conclusions:

  • Surgical management is crucial for reversing left ventricular remodeling in CHF.
  • A combination of surgical procedures is frequently necessary for comprehensive heart failure treatment.
  • Future innovations in regenerative medicine and tissue engineering offer hope for improved CHF therapies.

More Related Videos

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats07:41

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats

Published on: March 1, 2022

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...